WO1995022346A1 - Use of ceruletide diethyl amine salt in the treatment of psoriasis - Google Patents

Use of ceruletide diethyl amine salt in the treatment of psoriasis Download PDF

Info

Publication number
WO1995022346A1
WO1995022346A1 PCT/IB1995/000282 IB9500282W WO9522346A1 WO 1995022346 A1 WO1995022346 A1 WO 1995022346A1 IB 9500282 W IB9500282 W IB 9500282W WO 9522346 A1 WO9522346 A1 WO 9522346A1
Authority
WO
WIPO (PCT)
Prior art keywords
badges
ceruletide
psoriasis
amine salt
treatment
Prior art date
Application number
PCT/IB1995/000282
Other languages
French (fr)
Inventor
Lamara Feokharovna Kelesheva
Original Assignee
Theokhar Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theokhar Ltd. filed Critical Theokhar Ltd.
Priority to JP7521701A priority Critical patent/JPH08509245A/en
Priority to EP95914489A priority patent/EP0696203A1/en
Priority to MX9504335A priority patent/MX9504335A/en
Priority to AU21465/95A priority patent/AU2146595A/en
Publication of WO1995022346A1 publication Critical patent/WO1995022346A1/en
Priority to NO954115A priority patent/NO954115L/en
Priority to FI954912A priority patent/FI954912A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2207Gastrins; Cholecystokinins [CCK]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Definitions

  • the purpose of the present invention is the use of ceruletide diethyl amine salt (Takus) for the treatment of psoriasis.
  • Ceruletide a well known decapeptide first extracted from the skin of Hyla caerulea, the Australian frog, and then prepared by synthesis, has the following formula:
  • ceruletide diethyl amine salt administered by a single intramuscular injection in the dose from 2.5-5.0 ⁇ g, led to a significant improvement of the affection in all of the patients, with no exception, such an improvement lasting for 1-3 months.
  • the sleep improvement, the stabilisation of the moral state and the decrease of the itch were noted in the first days next to the application.
  • ceruletide diethyl amine salt Only one injection of ceruletide diethyl amine salt is normally sufficient for the treatment of psoriasis guttata.
  • a second injection of the formulation administered as well in doses of 2.5-5.0 ⁇ g is needed, paying attention to the individual sensibility of the patient toward ceruletide diethyl amine salt, in the presence of particularly resistant badges.
  • Diagnosis psoriasis nummularis, alcoholism.
  • Anamnesis the first symptoms of psoriasis appeared after a car accident that happened when he was 15 years old.
  • the badges on his forehead measured 2.5x3 and
  • badges of psoriasis guttata and other badges As large as a coin on the whole back. 25 badges of psoriasis guttata and nummularis were on the lateral part of his left thigh. 32 purple badges, measuring 4.5x5.5 cm 2 at most, mostly covered with scales, were on the internal part of the thigh. 28 badges measuring from 0.5x0.5 cm 2 to 1.8x2.0 cm 2 were on his right thigh.
  • a badge having a diameter of 5.0x6.0 cm 2 was noted on his front-upper left shin-bone, while the same zone of his right shin-bone was covered with 28 purple badges.
  • the badges on the back went pale and semicircular, the ones on his legs reduced.
  • the improvements of the skin disorder lasted for 3 months of the observation, when all of the badges disappeared: the positive effects being noticeable even after ten months.
  • the patient started to drink alcohol again, from time to time, till, after the last drink, a relapse of psoriasis occurred, which was customarily treated in a specialised clinic with vitamins, quartz lamps and liniment for 41 days. 3 days after the discharge from the clinic the patient started to drink alcohol again and during the next week all of the symptoms of the disease reappeared. Comparing the two treatments effected, the one with ceruletide diethyl amine salt protracted his beneficial effects for a longer time.
  • EXAMPLE 2 Patient N.I., woman, 35 years old, chronic gastritis
  • Diagnosis psoriasis figurata and guttata, chronic gastritis.
  • Anamnesis the first symptoms of psoriasis appeared after 2 months from an accident. The patient suffered from insomnia, amenorrhea and irritability. Some months after the accident some stains appeared on the contused part, and there were some stains on her chest and on her back. She was treated by vitamins, sedative drugs and tar ointment. The stains disappeared on the back and on the chest but reappeared on her face, arms and legs.
  • the skin was depigmented in the places of the treated stains.
  • the patient complains itch after bathing and badges on the knees, feet, abdomen and arms.
  • the depigmented badges acquired the normal skin colour again and the improvement lasted in an irreversible way for about 4 months till the disappearing of all of the badges. No skin disorder of this patient was noted after such a period and during 10 months of the observation.
  • EXAMPLE 3 patient CA. , man, 33 years old, single, engineer
  • Diagnosis psoriasis seborrhoica, chronic pyelonephritis.
  • the whole surface of the scalp was covered with the geriola form of psoriasis.
  • the patient was treated with a single injection of 3.0 ⁇ g of ceruletide diethyl amine salt.
  • the patient noted an improvement of the sleep and itch, and the stabilisation of the moral state.
  • EXAMPLE 4 The patient S. Sh., 22 years old, single, university student, plays basketball and track-and-field sports.
  • Diagnosis psoriasis guttata accompanied by gastritis.
  • the patient cured himself with hormonal, salicylic and sulphurous ointments, vitamins, quartz and sun bathing.
  • the badges went pale and disappeared leaving depigmented stains, yet they reappeared some weeks later.
  • small badges On the face small badges mainly disposed along the hairline.
  • small badges On the legs: small badges, disseminated on the back and on the side of tibiae and some badges on the knees.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The use of ceruletide diethyl amine salt in the treatment of psoriasis is claimed.

Description

USE OF CERULETIDE DIETHYL AMINE SALT IN THE
TREATMENT OF PSORIASIS
The purpose of the present invention is the use of ceruletide diethyl amine salt (Takus) for the treatment of psoriasis.
The treatment of this skin affection has been heretofore effected by using etretinate (Tigason)
which, however, slightly influences the damages that psoriasis may cause on skin keratisation. Moreover, said substance can develop tolerance and teratogenic effects, especially during a chronic treatment.
Ceruletide, a well known decapeptide first extracted from the skin of Hyla caerulea, the Australian frog, and then prepared by synthesis, has the following formula:
Pyr-Gln-Asp-Tyr-Thr-Gly-Trp-Met-Asp-PheNH2 I Sθ3H
the diethyl amine salt thereof being commercially named "Takus".
Therapeutically, it is used as a diagnostic agent in the investigation of the functional state of the gall bladder and pancreas, besides to being used as a stimulant of the gastric secretion. It has been surprisingly found that ceruletide diethyl amine salt can be used, with very good results, for the treatment of psoriasis.
The effectiveness of said substance in the treatment of different forms of psoriasis: psoriasis guttata, psoriasis figurata, psoriasis nummularis, psoriasis geografica and psoriasis seborrhoica has been ascertained in 12 volunteers (9 men and 3 women). The substance has been used alone in order to avoid synergistic pharmacological effects with other kinds of drugs, thus making possible to evaluate the positive effects per se on the skin affection.
The use of ceruletide diethyl amine salt, administered by a single intramuscular injection in the dose from 2.5-5.0 μg, led to a significant improvement of the affection in all of the patients, with no exception, such an improvement lasting for 1-3 months. The sleep improvement, the stabilisation of the moral state and the decrease of the itch were noted in the first days next to the application.
The disappearing of scales and a significant reduction of the badges, which became soft and pale and finally disappeared, were noted within 1-2 weeks.
Only one injection of ceruletide diethyl amine salt is normally sufficient for the treatment of psoriasis guttata.
A second injection of the formulation administered as well in doses of 2.5-5.0 μg is needed, paying attention to the individual sensibility of the patient toward ceruletide diethyl amine salt, in the presence of particularly resistant badges.
The skin of the badges acquired a normal colour during the treatment with ceruletide diethyl amine salt whereas, using an ointment of the commonly used type (for example mercury ointment), as an alternative, depigmentation was always noted. In the case of psoriasis concomitant with alcoholism, there was a full normalisation of the skin disorder after a single use of ceruletide diethyl amine salt, the positive effects of which lasted for about 5-6 months. After starting again with alcoholism, a relapse of psoriasis in the first 1-2 months from the renewed intake of alcohol was noted. Examples: EXAMPLE 1: Patient A.V. , man, 20 years old, single, cook
Diagnosis: psoriasis nummularis, alcoholism. Anamnesis: the first symptoms of psoriasis appeared after a car accident that happened when he was 15 years old.
2-3 months later the patient noted stains on his elbows and then the badges spread on his arms, legs, chest and shoulders. Exacerbation occurred especially during the winter months. The patient, when he was 17 years old, having the complicated inheritance of his father, became a chronic alcoholic: in the meantime he noted an aggravation of his condition too. Repeated treatments with tar ointments, cortisone liniments, vitamins and sedative drugs did not lead to any improvement: the badges could even disappear and then reappear in different places such as elbows and knees. The patient, when examined, complained itch and the presence of badges on his elbows, arms, legs, shoulders, forehead and around his ears.
The badges on his forehead measured 2.5x3 and
5.0x4.0 cm2; on the internal surface of his left elbow 6.0x5.0 cm2; 3.0x2.5 cm2 3.0x2.0 cm2; and a form of psoriasis guttata (23 badges) was present on his right elbow: 8.0x5.5 cm2, 8.0x2-5 cm2, 3x2.5 cm2 together with other 28 smaller badges.
There were badges of psoriasis guttata and other badges as large as a coin on the whole back. 25 badges of psoriasis guttata and nummularis were on the lateral part of his left thigh. 32 purple badges, measuring 4.5x5.5 cm2 at most, mostly covered with scales, were on the internal part of the thigh. 28 badges measuring from 0.5x0.5 cm2 to 1.8x2.0 cm2 were on his right thigh.
A badge having a diameter of 5.0x6.0 cm2 was noted on his front-upper left shin-bone, while the same zone of his right shin-bone was covered with 28 purple badges.
Treatment with ceruletide diethyl amine salt The patient was treated with a single injection of 4.9 μg of ceruletide diethyl amine salt. The day after the treatment, the patient A.V. noted a sleep improvement and decrease of the itch. Two weeks later, the badges became soft and pale: the ones on the back turned into a ring. Spaces, among the badges which were present on his forehead, elbows and legs appeared after one month.
The badges on the back went pale and semicircular, the ones on his legs reduced. The improvements of the skin disorder lasted for 3 months of the observation, when all of the badges disappeared: the positive effects being noticeable even after ten months. Then the patient started to drink alcohol again, from time to time, till, after the last drink, a relapse of psoriasis occurred, which was customarily treated in a specialised clinic with vitamins, quartz lamps and liniment for 41 days. 3 days after the discharge from the clinic the patient started to drink alcohol again and during the next week all of the symptoms of the disease reappeared. Comparing the two treatments effected, the one with ceruletide diethyl amine salt protracted his beneficial effects for a longer time.
EXAMPLE 2: Patient N.I., woman, 35 years old, chronic gastritis
Diagnosis: psoriasis figurata and guttata, chronic gastritis. Anamnesis: the first symptoms of psoriasis appeared after 2 months from an accident. The patient suffered from insomnia, amenorrhea and irritability. Some months after the accident some stains appeared on the contused part, and there were some stains on her chest and on her back. She was treated by vitamins, sedative drugs and tar ointment. The stains disappeared on the back and on the chest but reappeared on her face, arms and legs.
The skin was depigmented in the places of the treated stains.
The patient complains itch after bathing and badges on the knees, feet, abdomen and arms.
Dimensions of the badges: one badge measuring
5.5x6.0 cm2 on her left leg and two badges measuring 6.5x4.5 cm2 and 2.0x3.5 cm2 on her right knee; guttata forms of the badges were noted on her chest, back and on the medial part of her arms.
Treatment with ceruletide diethyl amine salt The patient was treated with a single injection of 4.5 μg of ceruletide diethyl amine salt. The patient noted the disappearing of irritability, itch and peeling of the badges the day after the treatment with an injection with ceruletide. The badges on her back and chest became pale and short spaces appeared among them after one week.
The depigmented badges acquired the normal skin colour again and the improvement lasted in an irreversible way for about 4 months till the disappearing of all of the badges. No skin disorder of this patient was noted after such a period and during 10 months of the observation.
EXAMPLE 3: patient CA. , man, 33 years old, single, engineer
Diagnosis: psoriasis seborrhoica, chronic pyelonephritis.
Anamnesis: psoriasis was diagnosed 7 years ago during the military service. The badges appeared on the forehead near the hair and then all of the scalp was covered with scales. Usually, every 2 months there were exacerbations of the psoriasis. After a treatment with mercury ointments there was only a temporary improvement, yet the badges did not disappear and became permanent. The patient, at the admission at the hospital complained an intense itch, peeling and the presence of badges on his scalp and of the "crown" on his forehead. The purple crown of the forehead measured 16x3.8 cm2.
The whole surface of the scalp was covered with the geografica form of psoriasis.
The largest and thickest badges were placed behind the ears. The patient was deeply depressed too.
Treatment with ceruletide diethvl amine salt
The patient was treated with a single injection of 3.0 μg of ceruletide diethyl amine salt.
The patient noted an improvement of the sleep and itch, and the stabilisation of the moral state.
During one week the badges became less thick and brown. 3 weeks later the badges behind the ears became thin and pale.
Large spaces appeared in the crown which began to divide into single pieces. The skin improvement lasted for 3 months.
A second injection of 2.7 μg was done after 4 months from the first one. A significant decrease of the peeling was obtained and the crown went paler.
The badges behind the ears were reduced and became pale and thin. The treatment was continued and after about 12 months no aggravation in his state, which was superimposable with the one resulting from the latest treatment, was noted.
EXAMPLE 4: The patient S. Sh., 22 years old, single, university student, plays basketball and track-and-field sports.
Diagnosis: psoriasis guttata accompanied by gastritis.
Anamnesis: psoriasis badges appeared first 14 months after the beginning of the treatment caused by an heavy stress provoked by a conflictual state.
Exacerbations occurred in autumn. Moreover, new badges appeared when pastry, cakes and other products of the same kind, having a high caloric value, were eaten.
The patient cured himself with hormonal, salicylic and sulphurous ointments, vitamins, quartz and sun bathing. The badges went pale and disappeared leaving depigmented stains, yet they reappeared some weeks later.
The last course of treatment - with a combined use of vitamins, 2% salicylic ointment, quartz and pine bathing was effected after 2 months from the beginning of the treatment with ceruletide.
Several badges on his face, legs, arms, chest and back were noted at the admission at the hospital.
On the face small badges mainly disposed along the hairline. On the legs: small badges, disseminated on the back and on the side of tibiae and some badges on the knees. On the arms: 5-6 badges, having a small diameter, for each shoulder.
On the chest: 6 badges having a diameter up to 1,5 cm; on the back 10 small badges mainly disposed in lateral upper zones. The patient complained periodical itch attacks, irritability, insomnia. Treatment with ceruletide diethyl amine salt After the injection of a single dose of 4.0 μg ceruletide diethyl amine salt, the patient noted a remarkable improvement of sleep, itch became less bothersome, his moral state improved. During the first 2-3 days next to the application of the drug, a slight exacerbation of the disease occurred: the number of the badges increased a few. Yet, after two weeks, all the badges went soft and pale, the scales disappeared. Then, the badges became paler and thinner, totally disappearing after about 1 month and a half the beginning of the treatment.
After the treatment with ceruletide diethyl amine salt no relapses of the disease were noted during the next 14 months.

Claims

CLAIMS 1. The use of the decapeptide ceruletide (Takus) diethyl amine salt
Pyr-Gln-Asp-Tyr-Thr-Gly-Trp-Met-Asp-PheNH2.NH(C2H5)2 I S03H
for the preparation of a medicament useful for the treatment of psoriasis.
2. The use according to claim 1, characterized in that the ceruletide diethyl amine salt is administered to the patient in a single dose of 2.5-5.0 μg.
3. The use according to claim 1, characterized in that the ceruletide diethyl amine salt is administered to the patient in two subsequent applications of 2.5-5.0 μg, considering the individual sensibility of the patient.
4. A composition for the treatment of psoriasis, characterized in that it comprises the decapeptide ceruletide diethyl amine salt
Pyr-Gln-Asp-Tyr-Thr-Gly-Trp-Met-Asp-PheNH2 • m(C 2 H 5^2
SO3H as pharmaceutical active ingredient.
PCT/IB1995/000282 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis WO1995022346A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP7521701A JPH08509245A (en) 1994-02-18 1995-02-13 Use of ceruletide diethylamine salt in the treatment of psoriasis
EP95914489A EP0696203A1 (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
MX9504335A MX9504335A (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis.
AU21465/95A AU2146595A (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
NO954115A NO954115L (en) 1994-02-18 1995-10-16 Use of ceruletide-diethylamine salt in the treatment of psoriasis
FI954912A FI954912A (en) 1994-02-18 1995-10-16 Use of ceruletide-ditylamine salt in the treatment of psoriasis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI94A000298 1994-02-18
ITMI940298A IT1274015B (en) 1994-02-18 1994-02-18 USE OF CERULETIDE (TAKUS) IN THE TREATMENT OF PSORIASIS

Publications (1)

Publication Number Publication Date
WO1995022346A1 true WO1995022346A1 (en) 1995-08-24

Family

ID=11367909

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB1995/000282 WO1995022346A1 (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis

Country Status (13)

Country Link
EP (1) EP0696203A1 (en)
JP (1) JPH08509245A (en)
AU (1) AU2146595A (en)
CA (1) CA2160251A1 (en)
FI (1) FI954912A (en)
HU (1) HU9503295D0 (en)
IL (1) IL112578A0 (en)
IT (1) IT1274015B (en)
MX (1) MX9504335A (en)
NO (1) NO954115L (en)
PL (1) PL311159A1 (en)
WO (1) WO1995022346A1 (en)
ZA (1) ZA951137B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3034531A1 (en) * 1980-09-12 1982-04-29 Farmitalia Carlo Erba S.p.A., 20159 Milano Analgesic use of tyrosine-O-sulphate poly:peptide cpds. - e.g. phyllo:caerulin and ceruletide in human and veterinary therapy
GB2095992A (en) * 1981-04-07 1982-10-13 Shionogi Seiyaku Kk Psycotropic drugs containing caerulein

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3034531A1 (en) * 1980-09-12 1982-04-29 Farmitalia Carlo Erba S.p.A., 20159 Milano Analgesic use of tyrosine-O-sulphate poly:peptide cpds. - e.g. phyllo:caerulin and ceruletide in human and veterinary therapy
GB2095992A (en) * 1981-04-07 1982-10-13 Shionogi Seiyaku Kk Psycotropic drugs containing caerulein

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE MEDLINE FILE SERVER STN KARLSRUHE; WALDMANN ET AL: "CONSERVATIVE TREATMENT OF SEVERE PARALYTIC ILEUS.CLINICAL EXPERIENCES WITH CERULETID" *
ED:BUDAVARI: "THE MERCK INDEX.ELEVENTH EDITION", MERCK & CO.,INC., RAHWAY,N.J.,USA *

Also Published As

Publication number Publication date
CA2160251A1 (en) 1995-08-24
IT1274015B (en) 1997-07-14
FI954912A0 (en) 1995-10-16
ITMI940298A0 (en) 1994-02-18
FI954912A (en) 1995-10-16
NO954115D0 (en) 1995-10-16
JPH08509245A (en) 1996-10-01
ITMI940298A1 (en) 1995-08-19
AU2146595A (en) 1995-09-04
EP0696203A1 (en) 1996-02-14
MX9504335A (en) 1997-05-31
HU9503295D0 (en) 1996-01-29
NO954115L (en) 1995-10-16
PL311159A1 (en) 1996-02-05
ZA951137B (en) 1995-12-01
IL112578A0 (en) 1995-05-26

Similar Documents

Publication Publication Date Title
Jiang et al. Auricular vagus nerve stimulation promotes functional recovery and enhances the post-ischemic angiogenic response in an ischemia/reperfusion rat model
Hamm Testosterone propionate in the treatment of angina pectoris
CA2643205A1 (en) Agent for correcting stress-inducing neuro-mediator, neuro- endocrine and metabolic disturbances and method for preventing and treating concomitant pathological conditions
JP2020019790A (en) Methods for treating prader-willi syndrome
JP2019537628A (en) Combination therapy
JP2001527537A (en) Use of a substance having oxytocin activity for the manufacture of a medicament for the treatment of affective pain syndrome
Ahmed et al. Efficacy of clarithromycin in pityriasis rosea
US5378686A (en) Therapeutic treatment of fibromyalgia
Taira et al. Antioxidative effects of a novel dietary supplement Neumentix in a mouse stroke model
BR112020006246A2 (en) METHOD FOR WEIGHT CONTROL OF A SUBJECT IN NEED
EP0696203A1 (en) Use of ceruletide diethyl amine salt in the treatment of psoriasis
Kauli et al. THE LH RESPONSE TO LH‐RELEASING HORMONE IN CHILDREN WITH TRUE ISOSEXUAL PRECOCIOUS PUBERTY TREATED WITH CYPROTERONE ACETATE
Reinhold et al. THE EFFECTS OF GLYCINE (GLYCOCOLL) IN MUSCULAR DYSTROPHY: WITH ESPECIAL REFERENCE TO CHANGES IN STRUCTURE AND COMPOSITION OF VOLUNTARY MUSCLE
Kadlubowska et al. Systemic contact dermatitis caused by inhaled cashew oil smoke.
Jungkunz et al. Acute effects of the synthetic analogue of methionine enkephalin FK 33-824 on depressive symptoms
AU611961B2 (en) Pharmaceutical preparation for curing multiple sclerosis and lateral amyotrophic sclerosis
Mazal Transient ischaemic attacks and increased platelet aggregability associated with oral contraceptives. Treatment with dipyridamole and aspirin.
Smith Tongue Changes in British Troops
RU2119350C1 (en) Agent for treatment of patients with psoriasis
SU1667865A1 (en) Method for treatment and prophylaxis of postcalving hydrocalciemia in cows
Sterk Alopecia Areata-Current and Emerging Therapies
Song et al. Sarcopenia and Sarcopenic Obesity–A Brief Review
US10279004B2 (en) Methods and compositions for enhancing or maintaining fertility
JP2024506953A (en) PLAQUE Improvement effect of Tapinarov in the treatment of psoriasis, atopic dermatitis, and radiation dermatitis
Bishop et al. Behavioral toxicity associated with benzquinamide (Quantril) therapy in schizophrenic patients

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NL NO NZ PL PT RO RU SD SE SI SK TJ TT UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 1995 530239

Country of ref document: US

Date of ref document: 19951010

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2160251

Country of ref document: CA

Ref document number: 283429

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 954912

Country of ref document: FI

WWE Wipo information: entry into national phase

Ref document number: 1995914489

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 1995914489

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1995914489

Country of ref document: EP